T1	Disease 28 44	Hepatic fibrosis
#1	AnnotatorNotes T1	DOID:5082
T10	Drug 372 375	TAA
T11	Drug 478 481	TAA
T12	Chemical 524 531	alanine
T13	Chemical 556 565	aspartate
T14	Chemical 622 632	γ-glutamyl
T15	Drug 701 704	TAA
T16	Drug 739 742	TAA
T17	Biomarker 775 843	α-smooth muscle actin (α-SMA) expression was significantly increased
T18	Drug 864 867	TAA
T19	Disease 938 946	fibrosis
#10	AnnotatorNotes T19	D005355
T2	Biomarker 134 156	chronic liver diseases
#11	AnnotatorNotes T2	not found
T20	Chemical 994 1008	hydroxyproline
T21	Drug 1026 1029	TAA
T22	Disease 1061 1063	ED
T23	Chemical 1087 1098	glutathione
T24	Chemical 1100 1103	GSH
T25	Chemical 1143 1153	superoxide
T26	Drug 1182 1185	TAA
T28	Chemical 1225 1240	malondialdehyde
T29	Chemical 1242 1245	MDA
T3	Chemical 213 221	estrogen
T30	Drug 1271 1274	TAA
T31	Drug 1330 1333	TAA
T33	Biomarker 1431 1530	increases in interleukin-6 (IL-6) and tumor necrosis factor-α (TNF-α) concentrations were exhibited
T35	Drug 1534 1537	TAA
T36	Disease 1584 1592	fibrosis
#26	AnnotatorNotes T36	DOID:0050855
T38	Disease 1678 1680	ED
T39	Drug 1693 1696	TAA
T4	Disease 213 232	estrogen deficiency
#29	AnnotatorNotes T4	not found
T40	Biomarker 1752 1754	ED
T41	Disease 1783 1799	hepatic fibrosis
T5	Disease 234 236	ED
T6	Disease 250 266	hepatic fibrosis
#33	AnnotatorNotes T6	DOID:5082
T7	Drug 272 285	thioacetamide
T8	Drug 287 290	TAA
T9	Disease 311 319	Fibrosis
#36	AnnotatorNotes T9	D005355
T42	Biomarker 65 119	persistent deposition of extracellular matrix proteins
T43	Collection 65 156	persistent deposition of extracellular matrix proteins and occurs in chronic liver diseases
R1	Association Arg1:T43 Arg2:T1	
#2	AnnotatorNotes T5	not found
#3	AnnotatorNotes T7	CHEMBL38737
#4	AnnotatorNotes T8	CHEMBL38737
R2	Causes Arg1:T10 Arg2:T9	
T44	Gene-Protein 524 548	alanine aminotransferase
T45	Gene-Protein 550 553	ALT
T46	GeneFamily 556 582	aspartate aminotransferase
T47	GeneFamily 584 587	AST
T48	Gene-Protein 590 610	alkaline phosphatase
T49	Gene-Protein 612 615	ALP
T50	GeneFamily 622 644	γ-glutamyl transferase
T51	GeneFamily 646 649	GGT
T52	Gene-Protein 775 796	α-smooth muscle actin
T53	Gene-Protein 798 803	α-SMA
T54	Gene-Protein 968 976	vimentin
T55	Gene-Protein 978 988	collagen-I
T56	Biomarker 968 1022	vimentin, collagen-I, and hydroxyproline, in the liver
T57	Biomarker 1073 1178	reduced total glutathione (GSH) levels, as well as catalase (CAT) and superoxide dismutase (SOD) activity
R4	Association Arg1:T57 Arg2:T22	
T58	Gene-Protein 1124 1132	catalase
T59	Gene-Protein 1134 1137	CAT
T60	GeneFamily 1143 1163	superoxide dismutase
T61	GeneFamily 1165 1168	SOD
T27	Gene-Protein 1377 1380	p53
T32	Gene-Protein 1382 1387	Bcl-2
T62	Gene-Protein 1401 1410	caspase 3
T63	Gene-Protein 1444 1457	interleukin-6
T64	Gene-Protein 1459 1463	IL-6
T65	Gene-Protein 1494 1499	TNF-α
T66	Gene-Protein 1469 1492	tumor necrosis factor-α
R5	Association Arg1:T33 Arg2:T36	
T34	GeneFamily 1605 1633	transforming growth factor-β
T37	GeneFamily 1642 1646	Smad
T67	GeneFamily 1635 1640	TGF-β
R6	Association Arg1:T40 Arg2:T41	
T68	Biomarker 518 679	serum alanine aminotransferase (ALT), aspartate aminotransferase (AST), alkaline phosphatase (ALP), and γ-glutamyl transferase (GGT) were significantly increased
T69	Biomarker 1368 1417	elevated p53, Bcl-2, and cleaved caspase 3 levels
T70	Biomarker 1217 1253	hepatic malondialdehyde (MDA) levels
